Erratum to: Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib

The original version of this article contained a mistake in the author name. The author François F. Kavelaars should be presented as François G. Kavelaars.

Author information

Authors and Affiliations

Department of Hematology, Erasmus University Medical Center, Cancer Institute Daniel den Hoed, Groene Hilledijk 301, 3075, Rotterdam, The Netherlands
Emanuele Ammatuna, Matthias Eefting, Kirsten van Lom, François G. Kavelaars, Peter J. M. Valk & Ivo P. Touw

Authors

Emanuele Ammatuna
View author publications
You can also search for this author in PubMed Google Scholar
Matthias Eefting
View author publications
You can also search for this author in PubMed Google Scholar
Kirsten van Lom
View author publications
You can also search for this author in PubMed Google Scholar
François G. Kavelaars
View author publications
You can also search for this author in PubMed Google Scholar
Peter J. M. Valk
View author publications
You can also search for this author in PubMed Google Scholar
Ivo P. Touw
View author publications
You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Emanuele Ammatuna.

Additional information

The online version of the original article can be found at http://dx.doi.org/10.1007/s00277-014-2272-0.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ammatuna, E., Eefting, M., van Lom, K. et al. Erratum to: Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib. Ann Hematol 94, 1079 (2015). https://doi.org/10.1007/s00277-015-2356-5

Download citation

Published: 31 March 2015
Issue Date: June 2015
DOI: https://doi.org/10.1007/s00277-015-2356-5

Use our pre-submission checklist

Avoid common mistakes on your manuscript.